EDGAR Filing Documents for 0001628280-24-008056

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001628280-24-008056

Filing Date

2024-02-29

Accepted

2024-02-29 17:14:29

Documents

Effectiveness Date

2024-02-29

Document Format Files

Seq	Description	Document	Type	Size
1	S-3ASR	zentalis-sx3asr.htm	S-3ASR	402902
2	EX-FILING FEES	zentalisexhibit107-sx3asr.htm	EX-FILING FEES	69489
3	EX-1.2	zentalisexhibit12-sx3asr.htm	EX-1.2	284177
4	EX-4.3	zentalisexhibit43-sx3asr.htm	EX-4.3	433868
5	EX-5.1	zentalisexhibit51-sx3asr.htm	EX-5.1	42869
6	EX-23.2	zentalisexhibit232-sx3asr.htm	EX-23.2	3103
7		lathama.jpg	GRAPHIC	77458
8		zenalis_primarybluenavy.jpg	GRAPHIC	68307
	Complete submission text file	0001628280-24-008056.txt		1432861

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277545 | Film No.: 24705089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)